TW200906431A - Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof - Google Patents

Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof Download PDF

Info

Publication number
TW200906431A
TW200906431A TW96144911A TW96144911A TW200906431A TW 200906431 A TW200906431 A TW 200906431A TW 96144911 A TW96144911 A TW 96144911A TW 96144911 A TW96144911 A TW 96144911A TW 200906431 A TW200906431 A TW 200906431A
Authority
TW
Taiwan
Prior art keywords
red
extract
vine
solvent
chicken
Prior art date
Application number
TW96144911A
Other languages
Chinese (zh)
Other versions
TWI331921B (en
Inventor
Ji-Hua Chen
Xiu-Wen Chen
yuan-yi Zhang
Wen-Kai Liu
Original Assignee
Food Industry Res & Dev Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Industry Res & Dev Inst filed Critical Food Industry Res & Dev Inst
Priority to TW96144911A priority Critical patent/TW200906431A/en
Priority to JP2008183769A priority patent/JP5156515B2/en
Publication of TW200906431A publication Critical patent/TW200906431A/en
Application granted granted Critical
Publication of TWI331921B publication Critical patent/TWI331921B/zh
Priority to US13/098,142 priority patent/US8273388B2/en

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a Polygonum multiflorum (Taiwan Tuber Fleeceflower) extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof. The present invention discloses a Polygonum multiflorum extract capable of improving the metabolic syndrome. The present invention also discloses a pharmaceutical composition containing Polygonum multiflorum extract for improving the metabolic syndrome. The present invention further discloses a food composition containing Polygonum multiflorum extract suitable for patients with the metabolic syndrome. A simple preparation method is applied in the present invention to produce the invented extract and compositions, and it is verified that the invented extract and compositions have the functions of regulating blood-sugar and blood-lipid , inhibiting the activities of glucosidase and acetyl-CoA carboxylase (ACC), as well as promoting the activities of acyl-CoA oxidase (ACO). Therefore, the present invention only needs to use a single Polygonum multiflorum extract to achieve the effect of improving the metabolic syndrome.

Description

200906431 九、發明說明: 【發明所屬之技術領域】 本發明係一種紅雞屎藤萃取物,尤其是一種含有能夠 抑制腸道糖解酵素和肝臟中乙醢輔酶A緩化酵素(aCety卜 CoA carboxylase,ACC)之活性,並促進肝臟中醯基輔酶A 氧化酵素(Acy卜CoA oxidase, AC0)之活性,以改善代謝 症候群的紅雞屎藤萃取物。 【先前技術】200906431 IX. Description of the Invention: [Technical Field of the Invention] The present invention relates to a red pheasant extract, in particular to a saccharide-reducing enzyme (aCety-CoA carboxylase) capable of inhibiting intestinal glycolytic enzymes and liver. , ACC), and promotes the activity of 醯Kease A oxidase (AC0) in the liver to improve the metabolic syndrome of the red chicken vine extract. [Prior Art]

美國弟5,531,991號專利案揭露一種「利用何首良 萃取物治療血糖過高症的組成物 與方法」,其係一種將何首烏以〇.彳N的氫氧化銨萃取所 得之萃取物,經過葡聚凝膠G_25(Sephadex g_25)劃分為 3個組份(fraction),而何首物萃取物具有類似增加胰島素 活性的功效以及調節血糖的功能。 而在美國第6’200,569號專利案中揭露一種「增加胰 島素活性的組成物與方法」,其係一種利用何首良 ⑽刪⑺卿臟〇議)與伞菌科㈣㈣咖扣)的細菌或 銀葉桂(c丨nnamomum mairei)所級成的複方水萃物嗜複 方水萃物具有增加胰島素活性之功效,並有調節血糖的功 能0 然而,以上兩件美國專利揭係利用何首烏㈣辦_ miV/i//7〇R/n7)作為原料,並且以掸 _ s加胰島素活性的機制來調 即血糖,因此不且右墙銘 有°周卽血月曰的作用,更不具有改善代謝 症候群的功效。 ^八通 200906431 另外’在EP1 82951 9A1的專利案中一種「用於治療 和/或防止血脂過高症的醫藥組合物以及製造和使用該醫藥 組合物的方法」,其係揭露由何首烏、山I、丹篆和山七 的萃製物,按-定比例所組成的複方組合物,該複方組合 物具有調節血脂的功能H此結果僅呈現於人體試驗 結果’並未揭露可能的作用機制。 然而,上述歐洲專利是利用何首烏作為原料,並且必 須搭配其他萃製物所形成的複方組合物材具有調節血脂的 作用,但其並未揭露具有調節血糖或者改善代 效果。 —综上所述,既有的降金糖或降血脂的組合物皆係利用 :般傳統的何首烏(P。㈣。_ m着/〇叫,其原產地在 根國大陸’而且傳統何首烏的藥用部分在於其肥大的塊 的藥:Ϊ人目刖市面上只有降Α脂或是降血糖等單-功能 :、或艮品,並無針對代謝症候群發展藥物或食品。缺 餘:謝症候群發生的情形越來_,因此本研究即係 有抑制腸道糖份的吸收、抑㈣㈣ 關::氧化的植物性原'料’以開發出解決代謝症候群的Γ 【發明内容】 烏有馨於目前所利用的何首烏皆為傳統何首 I僅有卜的降血糖或者降血丨旨的:力能 有關冶療代謝症料的研究心 .、、、任何 U此經過長時間的研究 200906431 以及不斷的嘗試之後,終於發明出具有改善代謝症候群功 能的紅雞屎藤萃取物。 本發明之目的係在於提供一種單獨利用紅雞屎藤(又名 口灣何首烏)的萃取物,使其抑制腸道糖解酵素和肝臟中乙 輔酶 A 缓化酵素(acety卜c〇a carboxylase,ACC)之活 性,亚促進肝臟中醯基輔酶八氧化酵素(acy|_c〇A AC0)之活性,以用於改善代謝症候群的紅雞辱藤萃取物。’ 為達上述目的,本發明係相關於一種用於改善代謝症 候群的紅痛原藤萃取物’其係包括以下述方法所製備:提 供新鮮或經乾燥之紅雞屏藤植株或局部;以溶劑萃取該紅 雞原藤植株或局部以獲取溶劑萃取物;濃縮乾燥該㈣萃 取物;及獲取該紅雞屎藤萃取物。 較佳的是,所提供之紅雞屎藤局部係莖部與根部。 較佳的是,萃取該紅雞#藤植株或局部的溶劑可為 水、醇類、醇類水溶液以及乙酸乙自旨,其中水尚可於升古 的溫度下進行紅料藤植株或局部的萃取,其係可將^ 二:熬藥之藥壺内’直接將紅雞辱藤植株或局部加 …’更佳的是該溶劑為濃度在&〜_wt%的純乙醇或 ⑽水溶液’最佳的乙醇濃度為7Q〜⑽爾;最佳的β 酵類溶劑係含有鹽酸的酸性酒精。 '疋 較佳的是,萃取該紅雞屏藤莖部與根部係使用酸 精’在紅雞屎藤重量與酸性酒精體積約為1:5至”n / 例範圍内,於室溫下進行。 ’的比 本發明係相關於一種用於改善代謝症候群之醫藥組合 200906431 雞原藤萃取物及醫藥上可接受的载劑或賦形 締r燥'"紅雞原藤萃取物的製傷步驟包括:提供新鮮或 ,、工乾知之紅雞屎藤植株或局 一 株或局部以獲取溶劑萃取物.、曲合劑卒取該紅雞原藤植 取紅雞_取物;及將該紅取物;獲 接受的載劑或賦形劑製成醫筚二:卒取“加醫藥上可 候群之用。 4成i組合物,以作為改善代謝症 :交佳的是’所提供之紅雞辱藤局部係莖部與根部。 水、m,萃取該紅雞原藤植株或局部的溶劑可為 二=醇類水溶液以及乙酸乙醋,其中水尚可於升高 人::::::红嶋植株或局部的萃取,其係可將水放 溫赛者,.\樂之藥壺内’直接將紅雞摩藤植株或局部加 乙醇二ΓΓ該溶劑為濃度在25,_%的純乙醇或 乙%水冷液,最佳的乙醇濃度為70〜100w 醇類溶劑係含有鹽酸的酸性酒精。,最佳的疋’ 精::::二:取該紅雞摩藤莖部與根部係使用酸性酒 =㈣勝重量與酸性酒精體積約為1:5至 灼乾圍内,於室溫下進行。 合物本相關於—種適合代謝症候群病人的食品組 新鮮或經萃取物,備步驟包括:提* 物獲取溶劑萃取物;濃縮乾燥該溶劑萃* 善代::::::卒取物;及製成食品組合物,為改 200906431 較佳的是,所提供之紅„藤局部係莖部與根部。 較佳的是’萃取該紅雞原藤植株或局部的溶劑可為 水、醇類、醇類水溶液以及乙酸乙§|,其中水尚可於升高 的溫度下進行紅雞屎藤植株或局部的萃取,其係、可將水放 入一般熬煮中藥之藥壺内,直接將紅㈣藤植株或局部加 溫熬煮;更佳的是該溶劑為濃度在25wt%的純乙醇或 ^醇水溶液’最佳的乙酵濃度為7〇〜1〇_% ;最佳的是, 醇類溶劑係含有鹽酸的酸性酒精。 較佳的是’萃取該紅㈣藤莖部與根部係使用酸性酒 精,在紅雞屎藤重量與酸性酒精體積約為1:5至1:2〇的比 例範圍内’於室溫下進行。U.S. Patent No. 5,531,991 discloses a "Composition and Method for Treating Hyperglycemia Using Heshouliang Extract", which is an extract obtained by extracting Polygonum multiflorum with ammonium hydroxide of 〇.彳N through a chlorinated gel. G_25 (Sephadex g_25) is divided into three fractions, and the extract of Heshou has similar effects of increasing insulin activity and regulating blood sugar. In the U.S. Patent No. 6,200,569, a "composition and method for increasing insulin activity" is disclosed, which is a kind of bacteria or silver leaf using He Shouliang (10) (7) and the agaricaceae (4) (4) The compound water extract of the compound water (C丨nnamomum mairei) has the effect of increasing insulin activity and has the function of regulating blood sugar. However, the above two US patents use the Polygonum multiflorum (4) to do _ miV/ i//7〇R/n7) is used as a raw material, and the blood sugar is adjusted by the mechanism of 掸_s plus insulin activity. Therefore, it does not have the effect of the blood wall of the right wall, and it does not improve the metabolic syndrome. efficacy. ^八通200906431 Further, in the patent of EP1 82951 9A1, a "pharmaceutical composition for treating and/or preventing hyperlipidemia and a method for producing and using the same," disclosed by Ho Shouwu, Shan I. The extract of Danqi and Shanqi, a compound composition consisting of - a proportional composition, which has a function of regulating blood lipids. This result is only presented in the human test results' and does not reveal a possible mechanism of action. However, the above-mentioned European patent utilizes Polygonum multiflorum as a raw material, and the compound composition which must be formed with other extracts has a function of regulating blood lipids, but it does not disclose the effect of regulating blood sugar or improving generation. - In summary, the existing composition of reducing gold or lowering blood fat is utilized: the traditional Chinese Polygonum multiflorum (P. (four). _ m / screaming, its origin in the mainland of the country' and the traditional Polygonum The medicinal part lies in its hypertrophic block: the scorpion sees only single-functions such as hypolipidemic or hypoglycemic on the market: or sputum, there is no drug or food for metabolic syndrome. Deficiency: Xie syndrome occurs The situation is more and more, so this study is to inhibit the absorption of intestinal sugar, and (4) (4) Guan:: oxidized phytoplasma 'material' to develop a solution to the metabolic syndrome Γ 【Abstract】 Wu Youxin at the present The use of Polygonum multiflorum is the traditional Heshou I only to reduce the blood sugar or blood loss of the purpose: the ability to study the metabolism of metabolic disease materials.,,, any U after a long period of research 200906431 and constant attempts After that, the extract of the red pheasant has been invented to improve the function of the metabolic syndrome. The object of the present invention is to provide an extract which utilizes the red pheasant (also known as Polygonum multiflorum) to inhibit intestinal glycolytic solution. yeast And the activity of Escherichia coenzyme (ACC) in the liver, and sub-promoting the activity of the 醯SK enzyme octadecylase (acy|_c〇A AC0) in the liver for improving metabolic syndrome. Red chicken vine vine extract. 'To achieve the above object, the present invention relates to a red pain vine extract for improving metabolic syndrome', which comprises the following method: providing fresh or dried red chicken vine a plant or a part; extracting the red hen or the vine from the solvent to obtain a solvent extract; concentrating and drying the (four) extract; and obtaining the red pheasant extract. Preferably, the red chicken vine is provided locally. Preferably, the solvent for extracting the red chicken #vine plant or the local solvent may be water, an alcohol, an aqueous alcohol solution, and an acetic acid, wherein the water is still red at a temperature of ascending ancient For the vine plant or partial extraction, the system can be used to treat the medicinal pot of the cockroach. The cockroach is directly added to the vine plant or the vine plant is added... It is better that the solvent is in the concentration of &~_wt% pure Ethanol or (10) aqueous solution 'best The concentration of ethanol is 7Q~(10); the best β-fermentary solvent is acidic alcohol containing hydrochloric acid. '疋 It is better to extract the red-skinned stem and the roots using the acid essence' in the weight of the red chicken With an acid alcohol volume of about 1:5 to "n / case, at room temperature. 'The present invention is related to a pharmaceutical combination for improving metabolic syndrome 200906431 Chicken vine extract and pharmaceutically acceptable The carrier or the shaped "roughing" of the red chicken vine extract includes the steps of: providing fresh or simmered red chicken vine plants or a plant or a part to obtain a solvent extract. Mixing the red chicken raw vines to take the red chicken _ extract; and taking the red extract; receiving the carrier or excipient into the doctor's sputum 2: the stroke "additional medicine can be used. 4% of the composition, in order to improve the metabolic syndrome: the best is the red stem of the vine stems and roots. The water, m, and the solvent for extracting the red vine or the partial vine can be a bis-alcohol aqueous solution and an ethyl acetate vinegar, wherein the water can still be raised by a human:::::: red sorghum plant or a partial extraction, the system The water can be placed in a warmer, and the 'Kezhi medicine pot' directly adds the red chicken Moto plant or the local ethanol to the solvent to a concentration of 25, _% pure ethanol or B% water-cooled liquid, the best The ethanol concentration is 70 to 100 w. The alcohol solvent is an acidic alcohol containing hydrochloric acid. , the best 疋 '精:::: 2: Take the red chicken Moss stem and roots using acid wine = (four) win weight and acid alcohol volume is about 1:5 to dry and dry, at room temperature get on. The composition is related to a fresh or extracted food group suitable for patients with metabolic syndrome, and the preparation steps include: obtaining solvent extract from the extract; drying and drying the solvent extract * Good generation:::::: Stroke; And the food composition is changed to 200906431. Preferably, the red vine is provided with a stem and a root. Preferably, the solvent for extracting the red vine or the local vine is water, alcohol, An aqueous alcohol solution and acetic acid §|, wherein the water can be subjected to extraction or local extraction of the red pheasant plant at an elevated temperature, and the water can be placed in a medicine pot of a general medicinal Chinese medicine, directly red (4) The vine plant is locally warmed and boiled; more preferably, the solvent is a pure ethanol or an aqueous alcohol solution having a concentration of 25 wt%, and the optimum concentration of the yeast is 7〇~1〇_%; optimally, the alcohol The solvent is an acid alcohol containing hydrochloric acid. It is preferred to extract the red (four) cane and roots using acidic alcohol, and the ratio of the weight of the red chicken vine to the acid alcohol is about 1:5 to 1:2 〇. Within the range 'at room temperature.

由於本發明之步驟簡單,且無需特殊的溶劑即可萃取 出有效能的紅料藤萃取物,因此成本低廉,而且針對腸 道中糖解酵素、肝臟巾乙醯輔酶A m化酵素(Acety|_c〇A carb〇xyiase,ACC)進行實驗*,證實確有㈣的效果,並 且能夠促進肝臟中醯基_ A氧化酵素(AGy|_CQA⑽d咖, ACO)的活性’因此,本發明僅f利用單_的紅料藤萃取 物’即可同時達到調解血脂並調節血糖的功能,並具有改 善代謝症候群的功效。 【實施方式】 請參看第-圖所示’本發明係相關於—種用於 謝症候群的紅料藤萃取物,其係以下述方法所製備^ 包括提供新鮮或經乾燥之紅雞原藤植株或局部⑻;以溶劑 萃取該紅《藤植株或局部以獲取溶劑萃取物(b);濃 9 200906431 燥該溶劑萃取物(c);以及獲取 後尚可包含製備含該紅雞辱藤萃取物卒取物(心之 含該紅雞«萃取物的食品組合物=的醫樂組合物⑷或包 本發明係首先利用溶劑對新鮮或 株進行萃取,利用溶劑將紅雞耳紅雞屏、藤植 活性成分加以溶出,並進一步:=:可溶於溶劑内的 士八^ 7和用6玄可溶於溶劑内的活性 2盘處理腸道糖解酵素及肝臟中的酵素,發現其能 :糖與血脂調控關鍵酵素活性。在本發明之具體實施例 中,可以發現利用該可溶於溶劑内的活性成分具有抑制腸 道糖解酵素、肝臟乙醢_ A㈣酵素之活性,並能促進 肝細胞酿基制A氧化酵素之活性。因此,本發明所獲取 之紅雞#藤萃取物可進-步配合醫藥上可接受的載劑或賦 形劑’以製成治療代謝症候群之醫藥組合㈣相關保健食 品等。 本發明所指之『紅雞屏藤』又稱台灣何首烏(Taiwan Tuber F|eeceflower),其原產地為台灣,為台灣固有種, 不具有明顯的塊根,為傳統何首烏的變種,亦為中藥藥材 的一種’常見於台灣全島中低海拔山區,多生長於路邊及 林緣,但目前並未有人將台灣何首烏的根莖部替代傳統何 首烏來使用。紅雞屎勝係屬於蓼屬、装科 (P〇/yg〇A7aCeae) ’ 其學名可為 Po/yg〇A?i7/7? _耐/〇/__Since the steps of the present invention are simple, and the effective energy red vine extract can be extracted without special solvent, the cost is low, and the glycolytic enzyme and the liver sputum coenzyme A m enzyme (Acety|_c) are in the intestinal tract. 〇A carb〇xyiase, ACC) was tested* to confirm the effect of (iv) and to promote the activity of sulfhydryl-A oxidase (AGy|_CQA(10)d, ACO) in the liver. Therefore, the present invention uses only _ The red vine extract can simultaneously achieve the function of regulating blood lipids and regulating blood sugar, and has the effect of improving metabolic syndrome. [Embodiment] Please refer to the figure - the present invention relates to a red vine extract for use in Xie syndrome, which is prepared by the following method, including providing fresh or dried red chicken or vine plants or Partially (8); extracting the red "vine plant or part by solvent to obtain solvent extract (b); concentration 9 200906431 drying the solvent extract (c); and obtaining after preparation of the extract containing the red worm Taking the food composition containing the red chicken «the food composition of the extract = (4) or the invention of the invention first extracts fresh or strain with a solvent, and uses a solvent to red chicken ears and rattan The active ingredient is dissolved, and further: =: soluble in the solvent of Shiba 7 and 6 kinds of active 2 discs soluble in the solvent to treat intestinal glycolytic enzymes and enzymes in the liver, found that: sugar And blood lipids regulate key enzyme activity. In a specific embodiment of the present invention, it can be found that the use of the soluble active ingredient has the activity of inhibiting intestinal glycolytic enzyme, liver acetaminophen-A (tetra) enzyme, and promoting hepatocytes Stuffed A-oxidizing enzyme Therefore, the red chicken #vine extract obtained by the present invention can be further compounded with a pharmaceutically acceptable carrier or excipient to make a medical combination for treating metabolic syndrome (4) related health foods, etc. The invention refers to the "Red Chicken Pingteng", also known as Taiwan's Polygonum (Taiwan Tuber F|eeceflower). Its origin is Taiwan, which is an intrinsic species of Taiwan. It does not have obvious roots. It is a variant of the traditional Polygonum multiflorum. It is also a Chinese herbal medicine. One kind is common in the middle and low-altitude mountainous areas of Taiwan, and grows mostly on the roadside and forest edge. However, no one has replaced the roots of Taiwanese Polygonum multiflorum in the traditional Polygonum multiflorum. The red chicken is a genus of genus and genus (P 〇/yg〇A7aCeae) 'The scientific name can be Po/yg〇A?i7/7? _resistant/〇/__

Thunb. Ex murray var. hypoleucum (Ohwi) Liu, Ying & Lai ' Pleuropterus hypoleucus multiflorum, Polygonum hypoleucum Ohwi and Polygonum multiflorum Thunb. var. 200906431 (〇hw丨)Liu,Ymg & La卜其根與藤(莖)的部分 句鎮咳/·去風、怯痰’治療感冒咳嗷風濕等,·而葉部可 以治療感冒、外敷刀傷等。 本毛明所指之『代謝症候群(metab〇nc syndr〇me)』 意指姨島素阻抗症候群(心_「esistance syndrome),其 系心口肥胖所產生的第二型糖尿病患者所併發高血堡、高 ,脂等症狀。而胰島素阻抗性(insunn「esist_e)應為這 叢集的共同致病轉機’其係可藉由抑制腸道糖 =、抑制肝臟乙醯輔酶A幾化酵素、促進肝臟酿基輔 氣化酵素、控制血糖、血脂濃度而被改善。 雞岸=發月所和之『紅雞原藤萃取物』意指利用溶劑對紅 =植株進行萃取,以獲取紅雞原藤内可溶於溶劑的活 該溶劑可為水、醇類如乙醇、醇類水溶液以及乙 厚藤::了較佳係為酸性酒精。在本發明中,該紅雞 或經乾燥之全株植株或局部;局部可為 明雞Γ雞,藤莖部或紅雞原藤根部等;在本發 係扣紅雞屎滕莖部及根部。 本發明所指之F普始β π 康乾燥法以及二係可使用減壓濃縮法、冷 燥方法。 於本領域具有通常知識者所知的濃縮乾 本么明所指t『醫藥上可接受的載劑,斗— 物為口服型式,P,丨恭 』,右醫藥組合 作用位置前不受保護該醫藥組合物在尚未到達 又4化糸統的分解,而失 促進藥物的釋放以及效果。 放用,和/或能夠 11 200906431 — 斤私之醫藥上可接受的賦形劑』係為 藥物的均勻性、_ '、為了增加 穩疋性與減少藥物的刺激性、不良氣 醇、-粉或其他於本領域具有通常知識者所知二 候群萃取物,其係可製作成改善代謝症 口服給予形式:=τ給予不同的形式’包括但不限於 大,、包括单獨新穎形式的紅雞原藤萃取 :二上可接受之載劑,口服給予的形式可選自包ί 由鍵劑1末、懸浮液、乳糜液、膠囊、顆粒、片劑1 丸、液體、酒精劑和含藥糖毁所組成之族群中。’、 以下實施例係為了具體說明本發明之技術手段 =本發明之紅制料取物與特定料作用後進行活性分 Κ施例1_紅雞屎藤萃取物的製備 酸性酒籍萃敌你7 : 將紅雞原藤以磨碎機研磨後,以酸性酒精(添 〇.1%鹽酸_))萃#,紅„藤之重量與酸性酒精之㈣ 的比料1:8(W/V=1/8),將其放置室溫令 用1000轉(rpm)的速度震盪萃取。 s σ 72小時後’以紗布做初步的㈣,所得㈣液再以每 …刪轉(「_的速率離心15分鐘,取上層液濃縮乾 燥成為酸性酒精萃取物’其萃取率約為6 9% 。 再將該萃取物複溶,使其濃度為5〇mg/m丨。 12 200906431 熱水革取物 將紅雞屎藤放入中藥壺熬煮約兩個小時,紅雞屎藤之 重量與水之體積比約為1:20 (W/V= 1/20),再以紗布過濾, 該濾液以冷凍乾燥的方式得到熱水萃取物,其萃取率約為 9.2% 。 再將該萃取物複溶,使其濃度與酸性酒精萃取物一樣 為50 mg/m卜以進行下述實驗。 實施例2 紅雞屎藤萃取物抑制α -葡萄糖苷酶(α · glucosidase) 以對石肖基苯-a -D-葡萄糖_ (p-nitrophenyl a -D-glucoside,pNP-G)受質分析法進行抑制α -葡萄糖苷酶活 性的分析。其方法係包括: 1·首先以鱗酸緩衝溶液(1 OOmM,pH 7.0)配置1 U/ml 的 α -葡萄糖芽酶(EC 3.2.1.20,G5003,Sigma-Aid rich Co., USA)溶液以及5x1〇_3M對硝基苯^.〜吡喃葡糖苷(p_ nitrophenyl a -D-glucopyranoside,pNP-G, Sigma-AldrichThunb. Ex murray var. hypoleucum (Ohwi) Liu, Ying & Lai 'Pleuropterus hypoleucus multiflorum, Polygonum hypoleucum Ohwi and Polygonum multiflorum Thunb. var. 200906431 (〇hw丨)Liu,Ymg & La Buchigen and vine (stem) Part of the sentence of antitussive / · go to the wind, 怯痰 'treatment of cold, cough, rheumatism, etc., and the leaf can treat colds, external wounds and so on. The term "metab〇nc syndr〇me" as used by Ben Maoming means 姨 ance 阻抗 impedance syndrome (heart esistance syndrome), which is associated with a type 2 diabetes patient with a heart-shaped obesity High, fat and other symptoms. Insulin resistance (insunn "esist_e" should be the common pathogenic turnaround of this cluster] can inhibit the intestinal sugar =, inhibit the liver acetaminophen coenzyme A, promote the liver Kiev gasification enzyme, blood sugar control, blood lipid concentration is improved. Chicken shore = hair and the "red chicken raw vine extract" means the use of solvent to extract red = plant to obtain red chicken raw vine soluble solvent The solvent may be water, an alcohol such as ethanol, an aqueous alcohol solution, and a thick vine: preferably, it is an acidic alcohol. In the present invention, the red chicken or the dried whole plant or part; The chicken broiler, the cane or the red vine root, etc.; in the hairline, the red pheasant stems and the roots of the stalks. The F-precipitation β π Kang drying method and the second line of the present invention can be concentrated under reduced pressure. Method, cold drying method. Generally known to the knowledge of the concentrated dry copy of the word "medicinally acceptable carrier, bucket - oral type, P, Yu Gong", right medicine combination position is not protected before the pharmaceutical composition in It has not yet reached the decomposition of 4 chemistries, but the release of the drug and the effect of the drug. Use, and / or can be 11 200906431 - medicinal acceptable excipients for the drug is the uniformity of the drug, _ ' In order to increase the stability and reduce the irritancy of the drug, the bad alcohol, the powder or other two-group extracts known to those of ordinary skill in the art, the system can be made into an oral administration form for improving metabolic syndrome: =τ The different forms are included, including but not limited to large, including the novel novel form of red hen, vine extract: two acceptable carriers, and the form for oral administration may be selected from the group consisting of the agent 1, the suspension, the chyle The liquid, the capsule, the granule, the tablet, the liquid, the alcohol, and the medicated sugar are destroyed. ' The following examples are for the purpose of specifically illustrating the technical means of the present invention = the red material of the present invention and Specific material action活性 Κ Κ Κ Κ Κ Κ Κ Κ 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备 制备The ratio of the weight of the red vine to the acid alcohol (4) is 1:8 (W/V = 1/8), and it is placed at room temperature and shaken at a speed of 1000 revolutions (rpm). After s σ 72 hours, the initial (4) is made with gauze, and the obtained (four) liquid is then cut (each at a rate of 15 minutes, and the upper layer is concentrated and dried to become an acidic alcohol extract) with an extraction rate of about 6 9%. The extract is reconstituted to a concentration of 5 〇mg/m 丨. 12 200906431 The hot water extract is put into the Chinese medicine pot for about two hours, and the weight of the red chicken vine is The volume ratio of water is about 1:20 (W/V = 1/20), and it is filtered with gauze. The filtrate is freeze-dried to obtain a hot water extract with an extraction rate of about 9.2%. Reconstitution, the concentration was 50 mg/m b as the acidic alcohol extract to carry out the following experiment. Example 2 The extract of E. sinensis inhibits α-glucosidase (α · glucosidase ) -D-glucoside (p-nitrophenyl a-D-glucoside, pNP-G) was analyzed by mass spectrometry to inhibit α-glucosidase activity. The method includes: 1. Firstly, scallop buffer solution (1 mM) , pH 7.0) Configure 1 U/ml α-glucosidase (EC 3.2.1.20, G5003, Sigma-Aid rich Co., USA) solution and 5x1 _3M ^ .~ nitrophenyl glucopyranoside (p_ nitrophenyl a -D-glucopyranoside, pNP-G, Sigma-Aldrich

Co.,USA)受質溶液備用。 2 隨後於96孔盤之每一孔洞,依序加入4〇微升(p丨) 的磷酸緩衝溶液(0_4 M,pH 7_0)、1〇微升(//丨)的α _葡萄糖 苷酶溶液,以及不同稀釋度之紅雞屎藤萃取物5〇微升("丨), 再加入去離子水至170微升("丨)。 3.讓培養箱在37°C的環境中預熱5分鐘後,加入3〇 u升(//丨)已經預熱的文質溶液,經充分震盪混合後,於37 13 200906431 °c的環境下作用ι 〇分鐘。 4.再以波長德奈米(nm)的光度分析儀(ρ。概 灯,Bi〇〇TekC〇.,USA)紀錄前後的吸光值,並们Go表示 P制50 /〇之α _葡萄糖苷酶活性所需的濃度。 示以酸性酒精萃取物以及熱水萃 請參看表1,其係顯 取物所得到的結果: lc5(p(萃取物 A/q/ml) — 酸性酒精萃 酸性酒精萃 熱水萃取物 取物#1 取物叹 -5·5±〇·5 6.5 + 0^7^ 」7_1±〇·4 精由表1可以得知紅雞原藤之酸性酒精和熱水萃取物 對於α _葡萄糖苷酶之活性皆有抑制的效果,其中又以酸性 酒精萃取物所得的效果為佳。 文 貫施例3.紅雞屎藤萃取物抑制不同糖解酵素活性的 分析 ~ 利用大鼠腸道酵素粗萃液(rat jntestinai acet〇ne powder, Sigma Chemica, Co., St. Louis, 的來源,給予不同糖類受質(麥芽糖、蔗糖和澱粉),以測 试酸性酒精紅雞屎藤萃取液對於不同糖解酵素活性的抑制 作用。 請參看表2,其係顯示利用酸性酒精紅雞屎藤萃取液 14 200906431 對於不同糖解酵素活性 活性抑制的情形: 的抑制情形,其亦使用丨c 5〇 來表示 表2.Co., USA) The solution was taken up. 2 Subsequently, 4 μL of microliter (p丨) phosphate buffer solution (0_4 M, pH 7_0) and 1 μL of micro-liter (//丨) α-glucosidase solution were added to each well of a 96-well plate. , and 5 liters of red broth extract ("丨) of different dilutions, add deionized water to 170 μl ("丨). 3. Allow the incubator to warm up in an environment of 37 ° C for 5 minutes, then add 3 〇 u liter (/ / 丨) preheated texture solution, after sufficient shaking and mixing, in the environment of 37 13 200906431 °c The next action is ι 〇 minutes. 4. Record the absorbance values before and after the wavelength of the nanometer (nm) photometric analyzer (ρ. lamp, Bi〇〇TekC〇., USA), and Go means that the P system 50 / α α _ glucoside The concentration required for enzyme activity. Refer to Table 1 for the description of the acidic alcohol extract and hot water extract. The results obtained are: lc5 (p (extract A/q/ml) - acidic alcohol extract acid alcohol extract hot water extract #1 取物叹-5·5±〇·5 6.5 + 0^7^ ”7_1±〇·4 Fine Table 1 shows the acidic alcohol and hot water extract of red chicken vines for α-glucosidase The activity has an inhibitory effect, and the effect obtained by the acidic alcohol extract is better. The application example 3. The inhibition of the activity of different glycolytic enzymes by the extract of the red pheasant vines~ The crude extract of the intestinal enzyme of the rat is used. (rat jntestinai acet〇ne powder, Sigma Chemica, Co., St. Louis, source of different sugars (maltose, sucrose and starch) to test the acid alcohol red carp vine extract for different glycolytic enzymes The inhibition of activity. Please refer to Table 2, which shows the inhibition of the activity of different glycolytic enzyme activities by the use of acidic alcohol red chicken vine extract 14 200906431, which also uses 丨c 5〇 to represent Table 2 .

由上述表2顯示’酸性酒精萃取物對於麥芽糖糖解酵 素_丨tase)、㈣糖解酵素(α丨咖)以及#、糖糖解酵 素(su⑽e)均有抑制的效果,而且抑制強度為麥芽糖糖解 酵素 >澱粉糖解酵素 >蔗糖糖解酵素。 實轭例4 ·紅雞屎藤脂溶性萃取物的製備 將紅雞屎藤以磨碎機研磨後,以濃度5〇wt%的甲醇水 溶液萃取,紅雞屎藤之重量與50wt%的曱醇水溶液之體積 比例為1 : 10(W/V=1/10),在室溫中震盪萃取24小時後 以不織布過;慮,所得之滤液加入等體積之乙酸乙酯(ethyl acetate)/水,搖動混合後進行液_液萃取,取上層的乙酸乙 酉曰層’再加入與乙酸乙酯等體積之5wt〇/〇碳酸氫鈉(sodium Bicarbonate,NaHCO」搖動混合,再去除碳酸氫鈉層,以 洗去游離脂肪酸,接著再濃縮乾燥乙酸乙酯層後,即可得 到所要的脂溶性萃取物,萃取率約為〇 · g 1 〇/〇。 15 200906431 該脂溶性萃取物以二曱基亞砜(Djmethyl Sulfoxide, DMso)複溶’使其濃度為10mg/m卜 實施例5_以紅雞屎藤酸性酒精萃取物及脂溶性萃取 物抑制乙酿辅酶A叛化酵素(Acety卜CoA carboxylase, ACC) 之活性分析 乙醢輔酶A羧化酵素(ACC)是脂肪酸合成的關鍵酵 素’其產物丙二醯基輔酶A (malony卜CoA)係脂肪酸合成 酵素(fatty acid synthase, FAS)之受質,且是肉酸素棕櫚 酿轉移酶(carnitin palmitoyl CoA transferase,CPT)的抑 制劑’因此抑制ACC不但可以抑制内生性脂質合成,也 可加速粒線體内脂肪酸的氧化。 自鼠肝純化ACC並進行測試,其步驟係參考Tanabe 等人的方法(Tanabe T., Nakanishi,S.,Hashimoto T., Ogiwara, H., Nikawa J., Numa S. 1981. Acetyl-CoA carboxylase from rat liver, Meth. Enzymol. 71(pt C): 5-一 16)。所得的結果如表3 : 表3· 抑制ACC活性百分比(%) 酸性酒精萃取物 i_0.05mq/ml) 61.27 + 5.4 脂溶性萃取物(〇.〇5mg/ml) 45.99 + 1 1.9 16 200906431Table 2 above shows that the 'acidic alcohol extract for maltose sugar decomposing enzyme _丨tase), (four) glycolytic enzyme (α丨咖), and #, sugar glycolytic enzyme (su(10)e) have inhibitory effects, and the inhibitory strength is maltose. Glycolysis > Caramel Dehydrogenase > Sucrose Glucose Enzyme Solid yoke example 4 - Preparation of fat-soluble extract of red pheasant vines After grinding with red grinder, the extract was extracted with a concentration of 5 〇 wt% aqueous methanol, and the weight of red pheasant and 50% by weight of sterol The volume ratio of the aqueous solution was 1:10 (W/V=1/10), and the mixture was shaken and extracted at room temperature for 24 hours, and then the fabric was added to an equal volume of ethyl acetate/water. After shaking and mixing, liquid-liquid extraction is carried out, and the upper layer of ethyl acetate layer is taken, and then mixed with 5 wt. of sodium bicarbonate (NaHCO) in an equal volume of ethyl acetate, and then the sodium hydrogencarbonate layer is removed. After washing away the free fatty acid, and then concentrating and drying the ethyl acetate layer, the desired fat-soluble extract is obtained, and the extraction rate is about 〇·g 1 〇/〇. 15 200906431 The fat-soluble extract is dimethyl sulfoxide. (Djmethyl Sulfoxide, DMso) reconstituted to a concentration of 10 mg / m. Example 5 - inhibition of Escherichia coli AES with A. Activity analysis of acetaminophen coenzyme A carboxylase (ACC) is The key enzyme for fatty acid synthesis, its product, malony, is a receptor for fatty acid synthase (FAS), and is a carnitin palmitoyl CoA transferase (CPT). Inhibitors' thus inhibiting ACC not only inhibits endogenous lipid synthesis, but also accelerates oxidation of fatty acids in the mitochondria. ACC was purified from rat liver and tested in the same way as Tanabe et al. (Tanabe T., Nakanishi, S., Hashimoto T., Ogiwara, H., Nikawa J., Numa S. 1981. Acetyl-CoA carboxylase from rat liver, Meth. Enzymol. 71(pt C): 5--16). Table 3: Table 3. Percentage of inhibition of ACC activity (%) Acidic alcohol extract i_0.05mq/ml) 61.27 + 5.4 Fat-soluble extract (〇.〇5mg/ml) 45.99 + 1 1.9 16 200906431

紅雞屎藤之酸性酒精及脂溶性萃 中制活性。再取酸性酒精萃取物 —圖所不’其為紅雞屎藤酸性酒 次果的線性變化,由此圖可得知 50%之ACC活性所需 紅雞屎藤酸性酒精萃取物促進醯基輔酶 氧化酵素(Acyl-CoA oxidase, ACO)的活性分析 酿基辅酶A氧化酵素(AC〇)為脂肪酸万氧化作用的關 鍵酵素,亦是過氧化物酶體增殖物激活受體σ (ppARCT)的 典型下游基因,可做為脂肪酸氧化代謝活性的指標。 本項分析是以適當密度接種H4丨丨EC3肝細胞於12孔 盤中,待趴附後,更換為含有不同濃度之已知能促進AC〇 表現之氣笨丁酯(C|0fibrate)4彳00微升/毫升(;c/|/m丨)之紅雞 屎藤酸性酒精萃取物,培養適當時間,吸去培養液後收集 細胞,針對AC0進行活性測試。 AC0活性測試係採用small等學者在研究期刊(Sma丨丨 GM_ Burdett K. ConNock MJ. 1985. A sensitive spectrophotometric assay for peroxisomal acy 卜 CoA oxidase. 8/〇c/7em/ca/ J〇t//77a/· 227:205-210.)中的方法。 請參看第三圖所示,其中第三(A)圖係表示利用不同濃度 (1 00//M、500#M、1 ΟΟΟρΜ)之氣苯丁醋在不同時間(48及 72小時)作用下所能促進ACO活性的程度;而第三(Β)圖 17 200906431 係表示利用1〇M/ml之紅雞屏、藤酸性酒精萃取物處理48 小時後之ACO活性增加倍數。 實施例7.紅雞屏'藤酸性酒精萃取物對於高脂誘發代 謝症候群C57BL/6 J小鼠的影響 C57BL/6J小鼠先以含3〇%(g/g)之奶油的高脂飼料银 養八週出現肥胖、高血脂、高騰島素血症等代謝症候 群症狀。將此出現代謝症候群症狀之小鼠任意分為兩組, 一組給予添加有3%(g/g)之紅雞屎藤酸性酒精萃取物的高 脂飼料(相當於小鼠體重每公斤給予15〇〇毫克之紅雞屎藤 酸性酒精萃取物(1500mg/kg body weight))(HF + No.11), 另一組維持高脂飼料為對照組(HF)。另有正常飼料對照組 (LF)。經五週餵食後,進行口服葡萄糖耐受性試驗 glucose tolerance test,0GTT),其結果如表四所示之 後犧牲小鼠,其最終體重以及血液生化分析結果如表五所 示0 表4.第5週口服葡萄糖耐受性測試時,各組小鼠血 糖之變化The activity of the acidic alcohol and fat-soluble extract of red chicken vine. Then take the acidic alcohol extract - the figure is not 'the linear change of the red wine 屎 vine acid wine sub-fruit, so the figure can be seen that 50% of the ACC activity required red chicken vine vine acid alcohol extract promotes 醯 Kiev enzyme Activity analysis of oxidase (Acyl-CoA oxidase, ACO) is a key enzyme for the oxidation of fatty acids, and is also a typical peroxisome proliferator-activated receptor σ (ppARCT). Downstream genes can be used as indicators of fatty acid oxidative metabolic activity. This analysis is to inoculate H4丨丨EC3 hepatocytes in a 12-well plate at an appropriate density. After being attached, the cells are replaced with different concentrations of gas butyl ester (C|0fibrate) which are known to promote AC〇 performance. The micro-liter/ml (;c/|/m丨) red chicken vine vine acid alcohol extract was cultured for a suitable time, and the cells were collected by aspirating the culture solution, and the activity test was performed for AC0. The AC0 activity test is conducted by a scholar such as Small (Sma丨丨GM_ Burdett K. ConNock MJ. 1985. A sensitive spectrophotometric assay for peroxisomal acy CoA oxidase. 8/〇c/7em/ca/ J〇t//77a /· 227:205-210.) method. Please refer to the third figure, where the third (A) diagram shows the use of different concentrations (1 00//M, 500 #M, 1 ΟΟΟρΜ) of phenyl butyl vinegar at different times (48 and 72 hours) The degree of ACO activity can be promoted; and the third (Β) Figure 17 200906431 shows the fold increase in ACO activity after 48 hours of treatment with 1 〇M/ml of red chicken screen and vine acidic alcohol extract. Example 7. Effect of Red Chicken Screen 'Vine Acid Alcohol Extract on High Lipid Induced Metabolic Syndrome C57BL/6 J Mouse C57BL/6J Mice First High-fat Feed Silver with 3〇% (g/g) Cream Eight weeks of symptoms of metabolic syndrome such as obesity, hyperlipidemia, and hypertonic acid. The mice with symptoms of metabolic syndrome were arbitrarily divided into two groups, and one group was given a high-fat diet supplemented with 3% (g/g) of red chicken vine vine acidic alcohol extract (equivalent to 15 kg per kg of mouse body weight). 〇〇mg of red chicken vine vinegar acid alcohol extract (1500mg/kg body weight) (HF + No.11), the other group maintained high fat diet as the control group (HF). There is also a normal feed control group (LF). After five weeks of feeding, the glucose tolerance test (0GTT) was performed. The results were sacrificed in mice as shown in Table 4. The final body weight and blood biochemical analysis results are shown in Table 5. Table 4 Changes in blood glucose in mice of each group at the 5-week oral glucose tolerance test

血糖(mmol/L) AUCion Omin 30min 60min 90min 1 20min (mmol*min/L) LF(n = 6.1±1. 10.37土 9.97±1. 8.75±1. 8.56±1. 656·3±93·3 a 14) 32a 1.45 a 25 a 52 a 55 a HF(n = 8.76± 12.27± 12.16± 12.25士 13.74± 961.2±76.3C 18 200906431Blood glucose (mmol/L) AUCion Omin 30min 60min 90min 1 20min (mmol*min/L) LF (n = 6.1±1. 10.37 soil 9.97±1. 8.75±1. 8.56±1. 656·3±93·3 a 14) 32a 1.45 a 25 a 52 a 55 a HF (n = 8.76 ± 12.27 ± 12.16 ± 12.25 ± 13.74 ± 961.2 ± 76.3C 18 200906431

示。上標不同字母 結果以平均值±標準偏差值(SD)表 代表有顯著差異性,p &lt; 〇,0 5。 表4 ,,„員示,’星五週供以紅雞屎藤酸性酒精萃取物,可 顯著降低高脂誘發代謝症候群C57BL/6m禁食血糖 ’)並且使其在口服葡萄糖耐受性測試之6 〇及9 〇分鐘 糖以及2小B守血糖曲線下面積(area謝⑽,auc) 月顯地車乂呵脂對照組者為低。顯示紅雞屎藤酸性酒精萃取 物不僅可以降低禁食血糖,並可改善葡萄糖耐受能力。 &amp;表5.餵食五週紅雞屎藤酸性酒精萃取物對於高脂誘 小鼠體重及血清生理指標的影響 血清三 血清總 血清姨 最 終 酸甘油 膽固醇 島 素 非酯化 瘦 素 體重 酯 (Serum Serum 脂肪酸 (Leptin (Serum (NEFA) ) TC) insulin TG) '--- (mol/ml) (mmol/l) (ng/ml) (mmol/|) (nq/ml) LF(n = 26.2 + 0.99土 2.62土 0·39± 1.27土 467土 1.2C 0.23b 0_43c 0.11b 0.16a 1557c 19 200906431 HF(n = ---- 37·0± 1·38± 6~7) 1.8a 0_18a HF + N 〇.11 (η 35.1± 1 ·14± =6 〜7) 3.2b 0_32b 4·68± _0.21a 3_69± 1.08b 1 ·63± 0.45a 1.28± 0.25a 〇_599± 0.2a 〇·462± 0.2b 5911± 16233 4204土 2209b 所顯示之數值為平均值±標準偏差值(SD) ,、’主統计分析,以P值(p_value)&lt;〇 〇5為基準 上標a、b、c代表有顯著差異性。 表5顯示,給予15〇〇mg/kg b吻之紅雞原藤 精萃取物可以顯著地降低因高脂飲食所引起的高膽 ^、南三酸甘油醋、高騰島素分泌以及血液中瘦素depth) ί辰度。 、—本發明係以簡單的製備方法所製成,且無需利用特殊 的洛劑或繁複的萃取步驟即可達成m本發明之方法 所萃取的紅雞原藤萃取物經過多項測試後,可證明盆且有 調節金糖、血脂之功能,又可抑制糖解酵素和乙酿辅酶a 竣化酵素之活性,還可促進醯基_ A氧化酵素之活性, 因此能夠改善代謝症料’對於代謝症候群患者而言可說 是一大福音。 以上所述’僅是本發明的較佳實施例,並非對本發明 :任:形式上的限制,任何所屬技術領域中具有通常知識 右在不脫離本發明所提技術特徵的範圍内,利用本發 明所揭示技術内容所作出局部更動或修飾的等效實施例, 20 200906431 並且未脫離本發明的技術特徵内容,均仍屬於本發明技術 特徵的範圍内。 【圖式簡單說明】 第一圖係本發明的製備流程圖。 第二圖係本發明之紅雞屎藤酸性酒精萃取物抑制乙 辅酶A羧化酵素之活性的線性圖。Show. Superscripts with different letters The results are significantly different in the mean ± standard deviation (SD) table, p &lt; 〇, 0 5. Table 4,, „Members, 'Stars for five weeks with red chicken vine vine acid alcohol extract, can significantly reduce high-fat-induced metabolic syndrome C57BL/6m fasting blood glucose') and make it in oral glucose tolerance test 6 〇 and 9 〇 minutes of sugar and 2 small B under the blood sugar curve area (area Xie (10), auc) The monthly sputum sputum is low in the control group. It shows that the red chicken vine vine acid alcohol extract can not only reduce the fasting Blood sugar, and can improve glucose tolerance. & Table 5. Effect of five-week red chicken vine vine acidic alcohol extract on body weight and serum physiological indexes of high fat-induced mice serum three serum total serum 姨 final acid glycerol cholesterol island Non-esterified leptin weight ester (Serum Serum fatty acid (Leptin (Serum (NEFA)) TC) insulin TG) '--- (mol/ml) (mmol/l) (ng/ml) (mmol/|) Nq/ml) LF(n = 26.2 + 0.99 soil 2.62 soil 0·39± 1.27 soil 467 soil 1.2C 0.23b 0_43c 0.11b 0.16a 1557c 19 200906431 HF(n = ---- 37·0± 1.38± 6~7) 1.8a 0_18a HF + N 〇.11 (η 35.1± 1 ·14± =6 ~7) 3.2b 0_32b 4·68± _0.21a 3_69± 1.08b 1 ·63± 0.45a 1.28± 0.25a 〇_599± 0.2a 〇·462± 0.2b 5911± 16233 4204 soil 2209b The values shown are the mean ± standard deviation value (SD), 'Main Statistical analysis, with the P value (p_value) &lt; 〇〇 5 as the benchmark superscript a, b, c represents a significant difference. Table 5 shows that 15 〇〇 mg / kg b kiss red chicken vine extract It can significantly reduce the gallbladder, triglyceride, hypertonic acid secretion and blood leptin depth caused by high-fat diet. - The present invention is made by a simple preparation method, Moreover, it is not necessary to use a special agent or a complicated extraction step to achieve the method of the invention. The red vine extract extracted by the method of the invention can prove the pot and has the functions of regulating gold sugar and blood fat, and inhibiting sugar. The activity of the enzyme and the coenzyme a catalyzed enzyme can also promote the activity of sulfhydryl _ A oxidase, so the improvement of the metabolic syndrome can be said to be a great boon for patients with metabolic syndrome. Is a preferred embodiment of the invention, not the invention: </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; The technical features of the present invention are still within the scope of the technical features of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS The first drawing is a flow chart of the preparation of the present invention. The second graph is a linear graph of the activity of the red chicken vine vine acidic alcohol extract of the present invention for inhibiting the activity of the acetyl-CoA carboxylase.

第二(A)圖係利用不同劑量之氣苯丁酯促進醯基輔 氧化酵素之活性的柱狀圖。 AThe second (A) graph is a histogram of the activity of oxynase in different doses of phenyl butyl acrylate. A

【主要元件符號說明】 之紅雞屎藤酒精萃 (a)提供紅雞屎藤[Main component symbol description] Red chicken vine vine alcohol extract (a) Provide red chicken vine

(e)製備醫藥組合物 (d)獲取紅雞屎藤萃取物 (f)製備食品組合物 21(e) Preparation of a pharmaceutical composition (d) Acquisition of a red chicken vine extract (f) Preparation of a food composition 21

Claims (1)

200906431 十、申請專利範圍: 1 一種紅雞屎藤萃取物,其係由包括以下步驟的 方法所製成: 提供新鮮或經乾燥之紅雞屎藤莖部與根部; 以醇類溶劑萃取該紅雞屎藤莖部與根部以獲取醇類溶 劑萃取物; ' 濃縮乾燥該醇類溶劑萃取物;及 獲取紅雞屎藤萃取物。 2 ·如申請專利範圍第χ項所述之紅雞原藤萃取 物、,其中萃取該紅雞屏'藤莖部與根部使用的醇類溶劑能與 水混合成為i辰度在25〜1〇〇vvt%的乙醇。 3如申咕專利範圍第1項所述之紅雞屎藤萃取 物,其中萃取該紅雞原藤莖部與根部使用的醇類溶劑為能 與水混合成濃度在70〜1 〇〇wt〇/0的乙醇。 4如申π專利&amp;圍第2或3項所述之紅雞原藤萃 取物,其中該乙醇進而含有鹽酸成為酸性酒精。 5 ·如中請專利範圍第4項所述之紅雞屏、藤萃取物, 其中萃取該紅雞屏藤Μ部與根部係使用酸性酒精,在 原藤重量與酸性酒精體積約為1:5至1:2Q的比例範圍、、, 於室溫下進行。 6.一種紅雞原藤萃取物,其製備步驟係包括: 提供新鮮或經乾燥之紅雞㈣輯或局部· 以溶劑萃取該紅雞原藤植株或局部以獲取溶劑萃取 22 200906431 濃縮乾燥該溶劑萃取物;及 獲取紅雞屎藤萃取物, 其中該紅雞屎藤萃取物係用於改善代謝症候群。 7 ·如申請專利範圍第6項所述之紅雞屎藤萃取物, 其中所提供之紅雞屎藤局部係根部與莖部。 8 .如申請專利範圍第7項所述之紅雞屎藤萃取物, 其中萃取該紅雞屎藤植株或局部的溶劑係 所組成的群組:水、醇類、醇類水溶液以及乙酸乙二物質 9 .如申請專利範圍第8項所述之紅雞屎藤萃取物, 其中該溶劑為能與水混合成濃度在25〜1GGwt%的乙醇。 1〇· ”請專利範圍第8項所述之紅雞屎藤萃取 ’其中該溶劑為能與水混合成濃度纟7q〜⑽㈣的乙 如甲請專利範圍第8項 物其中該乙醇進而含有鹽酸成為酸性酒精。 物,^萃請專利範圍第11項所述之紅雞原藤萃取 藤莖部與根部係❹㈣酒精,在 、,推辱藤重量與酸性酒精體 在 内,於室溫下進行。 主1·20的比例範圍 1 3 .如申請專利範圍第6至 紅雞原藤萃取物,^巾任-項所述之 糖解酵♦、抑制㈣ 謝症候群係包括抑制腸道 辅酶A氧化酵素、促進肝臟醯基 料調即血糖濃度以及調節血月旨濃度。 種用於改善代謝症候群的醫藥組合物,其係 23 200906431 劑,其 包括紅雞屏、藤萃取物及醫藥上可接受的載劑或賦形 中製備步驟包括: / 提供新鮮或經乾燥之紅雞屎藤植株或局部; 物; 以溶劑萃取該紅雞屎藤植株或局部 以獲取溶劑萃取 濃縮乾燥該溶劑萃取物; 獲取紅雞屎藤萃取物;以及 將紅雞屎藤萃取物加入醫藥上可接受的載劑或賦形 劑’以獲得醫樂組合物D 1 5 .如申請專利範圍第i 4項所述之用於改善代謝 症候群的醫藥組合物,其中所提供之紅雞屎藤局部係根部 與莖部。 1 6 ·如申清專利範圍第1 5項所述之用於改善代謝 症候群的醫藥組合物’其中在該紅雞屎藤萃取物的製備步 驟中,該溶劑係選自於以下物質所組成的群組:水、醇類、 醇類水溶液以及乙酸乙酯。 1 7 ·如申請專利範圍第1 6項所述之用於改善代謝 症候群的醫藥組合物,其中該溶劑為能與水混合成濃度在 25〜1 〇〇wt%的乙醇。 1 8 .如申請專利範圍第1 6項所述之用於改善代謝 症候群的醫藥組合物,其中該溶劑為能與水混合成濃度在 7〇〜1 OOwt%的乙醇。 19·如申請專利範圍第1 6項所述之用於改善代謝 症候群的醫藥組合物,其中該乙醇進而含有鹽酸成為酸性 24 200906431 酒精。 症候ΙΓ μ請專利範圍第19項所述之用於改善代謝 症候群的醫藥組合物,盆 使用酸性酒精,在红料H 雞原藤莖部與根部係 至㈠。 在、、工雞原藤重置與酸性酒精體積約為1:5 '的比例範圍内,於室溫下進行。 之用如申請專利範圍第14至20項中任一項所述 候代謝症候群的醫藥組合物,其中該改善代謝症 酵’係包括抑制腸道糖解酵素、抑制肝臟乙酿輔…化 ” 足進肝臟醯基辅酶A氧化酵音、A因々Λ·上杜曲 調節血脂濃度。 乳化酵素、-即血糖濃度以及 ^ , 2 2 —種適合代謝症候群病人的食品組合物,豆包 括紅雞屎藤萃取物,1製借+ 八 燥之包括:提供料或經乾 &lt;、、工雞屎藤植株或局部; 物;以溶劑萃取該紅雞原藤植株或局部以獲取溶劑萃取 濃縮乾燥該溶劑萃取物; 獲取紅雞屎藤萃取物;以及 謝症=:原藤萃取物製成食品組合物,以作為改善代 dr:專利範圍第2 2項所述之適合代謝症候 與莖部:K °°、且“勿’其中所提供之紅雞屎藤局部係根部 群姓24.如申請專利範圍第23項所述之適合代 '人的食品組合物,其中在該紅料藤萃取物的製二步 25 200906431 驟中,該溶劑係選自於以下物質所組成的群組:水、醇類、 醇類水溶液以及乙酸乙醋。 2 5 ·如申請專利範圍第2 4項所述之適合代謝症候 群病人的食品組合物,其中該溶劑為能與水混合成濃度在 25~1 〇〇wt%的乙醇。 2 6 ·如申請專利範圍第2 4項所述之適合代謝症候 群病人的食品組合物,其中該溶劑為能與水混合成濃度在 70〜1 OOwt%的乙醇。 2 7·如申請專利範圍第2 4項所述之適合代謝症候 群病人的H组合物,I中乙肖進而含酸成為酸性酒 精0 2 8 .如申請專利範圍第2 7項所述之適合代謝症候 群病人的食品組合拍^,盆tb St , ^ 物,、中卒取該紅雞屎藤莖部與根部係 使用酸性酒精,太么金备斤 ^ 在、,雞屎藤重置與酸性酒精體積約為1:5 1·2〇的比例範圍内,於室溫下進行。 2 9·如申請專利範圍第2 ? 之摘人乐至28項中任一項所述 之適s代謝症候群病 候群# ~的&amp; 口口組合物,其中該改善代謝# 伎群係包括抑制腸道糖解酵 酵素、促π ^ 、抑制肝臟乙醯輔酶Α羧化 調節血脂濃度。 酵素、調節血糖濃度以及 十一、囷式: 如次頁 26200906431 X. Patent application scope: 1 A red chicken vine extract, which is prepared by a method comprising the steps of: providing fresh or dried red chicken stalks and roots; extracting the red with an alcohol solvent The stems and roots of the chicken vines are obtained for obtaining an alcohol solvent extract; 'concentrating and drying the alcohol solvent extract; and obtaining the extract of the red chicken vine. 2 · The red vine extract of the red chicken as described in the scope of the patent application, wherein the alcohol solvent used for extracting the stem portion and the root of the red chicken screen can be mixed with water to become i~ degree at 25~1〇〇 Vvt% ethanol. 3. The red chicken vine extract according to claim 1, wherein the alcohol solvent used for extracting the stem portion and the root of the red chicken is mixed with water to a concentration of 70 to 1 〇〇wt〇/ 0 ethanol. [4] The extract of the red chicken vine as described in claim 2 or 3, wherein the ethanol further contains hydrochloric acid to become an acidic alcohol. 5 · The red chicken screen and vine extract according to item 4 of the patent scope, wherein the extract of the red chicken vine and the root system uses acidic alcohol, and the volume of the original vine and the acid alcohol is about 1:5. The ratio range of 1:2Q is performed at room temperature. A red chicken raw vine extract, the preparation step comprising: providing fresh or dried red chicken (four) series or partial · solvent extraction of the red chicken raw vine plant or part to obtain solvent extraction 22 200906431 concentrated drying the solvent extract And obtaining a red chicken vine extract, wherein the red pheasant extract is used to improve metabolic syndrome. 7. The extract of the red pheasant vine as described in claim 6 of the patent application, wherein the root portion and the stem portion of the red pheasant are provided. 8. The extract of the red pheasant vine as described in claim 7, wherein the group of the solvent of the red pheasant or the partial solvent is extracted: water, an alcohol, an aqueous alcohol solution, and an acetic acid Substance 9. The red chicken vine extract according to claim 8, wherein the solvent is ethanol which can be mixed with water to a concentration of 25 to 1 GGwt%. 1〇· "Please select the red chicken vine extract as described in item 8 of the patent scope", wherein the solvent is a mixture of water and water to a concentration of q7q~(10)(4), such as the third item of the patent scope, wherein the ethanol further contains hydrochloric acid. It becomes an acidic alcohol. The extract of the red vines and the roots of the red vines as described in the eleventh article of the patent scope (4) alcohol, at the room temperature, and the weight of the vines and the acid alcohol are carried out at room temperature. The ratio of the main 1·20 ranges from 1 to 3. According to the patent application range 6 to the extract of the red hen, the sugar syrup syrup, the inhibition (4) the syndrome group includes inhibition of the intestinal coenzyme A oxidase, Promoting liver sputum base, ie, blood sugar concentration and regulating blood concentration. A pharmaceutical composition for improving metabolic syndrome, which is a 23 200906431 agent, which includes red chicken screen, rattan extract and pharmaceutically acceptable carrier. Or the preparation step in the shaping comprises: providing fresh or dried red pheasant plants or parts; extracting the red pheasant plant or the part by solvent to obtain solvent extraction, concentrating and drying the solvent extraction Obtaining a red chicken vine extract; and adding the red chicken vine extract to a pharmaceutically acceptable carrier or excipient' to obtain a medical composition D 1 5 as described in claim i. The pharmaceutical composition for improving metabolic syndrome, wherein the root portion and the stem of the red pheasant are provided. 1 6 · The pharmaceutical composition for improving metabolic syndrome according to claim 15 of the patent scope of Shen Qing 'In the preparation step of the extract of the red pheasant, the solvent is selected from the group consisting of water, alcohols, aqueous alcohol solutions and ethyl acetate. 1 7 · as claimed in the patent scope The pharmaceutical composition for improving metabolic syndrome according to the above-mentioned item 6, wherein the solvent is ethanol which can be mixed with water to a concentration of 25 to 1% by weight, and is as described in claim 16 of the patent application. The pharmaceutical composition for improving metabolic syndrome, wherein the solvent is ethanol capable of mixing with water to a concentration of 7 〇 to 100% by weight. 19· for improving metabolic syndrome as described in claim 16 of the patent application. a pharmaceutical composition wherein the ethanol Further, hydrochloric acid is added to be acidic 24 200906431 Alcohol. Symptoms ΙΓ μ Please refer to the pharmaceutical composition for improving metabolic syndrome described in Item 19 of the patent range, using acidic alcohol in the pot, and the roots and roots of the red material H chicken are attached to (1). It is carried out at room temperature in the range of the ratio of the artificial vines to the original vines and the acid alcohol volume of about 1:5 。. The use of the metabolic syndrome according to any one of claims 14 to 20 The pharmaceutical composition, wherein the improved metabolic disease yeast system includes inhibition of intestinal glycolytic enzymes, inhibition of liver spleen supplementation, "into the liver, sputum, enzyme A oxidative tone, A, 上··················································· . Emulsifying enzymes, ie, blood sugar concentration and ^, 2 2 - a food composition suitable for patients with metabolic syndrome, beans including red chicken vine extract, 1 system + boring include: supply or dry &lt;, a chicken or vine plant or a part; a solvent; extracting the red vine or vine from a solvent to obtain a solvent extracting and concentrating and drying the solvent extract; obtaining an extract of red carp, and extracting the vine; The composition is used as an improved generation dr: the metabolic syndrome and the stem portion described in item 22 of the patent scope: K ° °, and "Do not use the red chicken vine root part root group name provided 24. The food composition suitable for the human being as described in claim 23, wherein in the process of preparing the red vine extract, in the second step of 25, 2009, 064, 31, the solvent is selected from the group consisting of water, Alcohols, alcoholic aqueous solutions, and ethyl acetate. 2 5 · A food composition suitable for patients with metabolic syndrome as described in claim 24, wherein the solvent is capable of mixing with water to a concentration of 25 to 1 〇〇 Wt% ethanol. 2 6) A food composition suitable for a metabolic syndrome patient as described in claim 24, wherein the solvent is ethanol capable of mixing with water to a concentration of 70 to 100% by weight. 2 7 · Patent Application No. 2 The composition of the above-mentioned H composition suitable for patients with metabolic syndrome, I, and the acid containing acid to become acidic alcohol 0 2 8 . The food combination suitable for patients with metabolic syndrome as described in claim 27 of the patent scope Tb St , ^ 物 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , In the range of ratios, it is carried out at room temperature. 2 9 · The application of the patent scope 2 之 乐 乐 乐 ~ ~ 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 28 The substance, which improves the metabolism of the 伎 包括 包括 包括 包括 包括 包括 包括 包括 包括 包括 包括 包括 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制 抑制26
TW96144911A 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof TW200906431A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TW96144911A TW200906431A (en) 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof
JP2008183769A JP5156515B2 (en) 2007-08-03 2008-07-15 A composition for improving metabolic syndrome, comprising an extract of Taiwan mulberryflorum humb. ExMurrayvar.
US13/098,142 US8273388B2 (en) 2007-08-03 2011-04-29 Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW96128525 2007-08-03
TW96144911A TW200906431A (en) 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof

Publications (2)

Publication Number Publication Date
TW200906431A true TW200906431A (en) 2009-02-16
TWI331921B TWI331921B (en) 2010-10-21

Family

ID=44723142

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96144911A TW200906431A (en) 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof

Country Status (1)

Country Link
TW (1) TW200906431A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102604803A (en) * 2012-03-28 2012-07-25 钟定良 Preparation method for ginseng-polygonum multiflorum nourishing solution

Also Published As

Publication number Publication date
TWI331921B (en) 2010-10-21

Similar Documents

Publication Publication Date Title
Lo et al. Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin
CN101683351B (en) Application of phlorizin in preparing hepatic or health-care food
CN103734751B (en) A kind of composite dietary and method for making thereof
CN102697035A (en) Cordyceps anti-aging pellet
CN109078011A (en) The application of iris aglycone and its derivative in prevention and treatment insulin resistance disease medicament
CN109999024A (en) Purposes of the Aspergillus terreus secondary metabolites-butyrolactone in preparation treatment diabetes medicament
CN102485237B (en) Sweet wormwood herb brewed liquid, and brewing technology thereof
CN108440292A (en) Different sequence Chinese tallow tree element A-H and its pharmaceutical composition and its application
CN104840778A (en) Traditional Chinese medicine fermented hair-blacking preparation, preparation method and purpose thereof
CN106902129B (en) Application of active ingredients of Trillium medicinal material in preparation of liver protecting or liver protecting medicine
KR20040032920A (en) Fermentation product of cyptoporus volvatus and its preparation method and use
CN103766901A (en) Application of andrographolide C to preparation of weight-losing food or medicine
TW200906431A (en) Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof
CN105012826A (en) Alpinia oxyphylla leaf extract and preparation method and application thereof
US8273388B2 (en) Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome
CN112089784A (en) Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating diseases caused by atherosclerosis
KR101228554B1 (en) The Fermentation Forming Method of Citrus Sunki And The Product thereof
KR101062003B1 (en) Composition for the prevention and the treament of diabetes containing Alnus firma Sieb. et Zucc extracts or compounds separated therefrom as an effective ingredient
CN103766455B (en) A kind of Chinese yam buckwheat class carbohydrase sandwich biscuits with health role to diabetes
JP5156515B2 (en) A composition for improving metabolic syndrome, comprising an extract of Taiwan mulberryflorum humb. ExMurrayvar.
CN110143989A (en) A kind of novel Ellagitannins class alpha-glucosidase restrainer and preparation method thereof
CN101406498A (en) Effective hypoglycemic component of may flower and preparation method and use thereof
CN108888750A (en) Cordyceps sinensis pueraria lobata compound with function of blood sugar reduction
CN104162163A (en) Application of acyl-coenzyme A oxidase as therapeutic target of diabetes
CN101356968B (en) Red Chinese fevervine extract and medical composition thereof and food composition and preparation method thereof